Investigation of Respiratory Functions, Inspiratory Muscle Strength, Physical Fitness and Aerobic Capacity in Patients With Parkinson's Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The aim is to examine respiratory functions, inspiratory muscle strength, respiratory function, physical fitness and aerobic capacity in Parkinson's disease patients. Individuals between the ages of 50-80 who have been diagnosed with Parkinson's disease by a neurologist and healthy individuals with similar demographic characteristics will be included in the study as a control group. In addition, patients will be divided into three groups as above and below 2.5 and healthy controls according to the Modified Hoehn and Yahr Scale. Demographic information of the individuals will be recorded and clinical evaluations will be made. The staging of Parkinson's patients will be done with the Modified Hoehn and Yahr Scale, and the severity of the disease will be done with the Unified Parkinson's Disease Rating Scale. The inspiratory muscle strength of the individuals will be evaluated with the PowerBreath K5, respiratory functions with the Pulmonary Function Test device, and physical fitness and aerobic capacity with the Senior Fitness Test.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
Healthy Volunteers: t
View:

• Age 50 to 80

• Mini Mental State Examination score of 24 to 30

• Diagnosed with Parkinson's Disease by a neurologist

Locations
Other Locations
Turkey
Atılım University
RECRUITING
Ankara
Contact Information
Primary
Büşra Seçkinoğulları Korkusuz, PhD
bskorkusuz@ankara.edu.tr
+905442436914
Time Frame
Start Date: 2025-07-01
Estimated Completion Date: 2025-10
Participants
Target number of participants: 100
Treatments
Early Stage Patients with Parkinson's Disease
According to the Modified Hoehn and Yahr Scale (MHÖ), patients with a score below 2.5
Advanced Stage Patients with Parkinson's Disease
According to the Modified Hoehn and Yahr Scale (MHÖ), patients with 2.5 and above
Control Group
Healthy individuals with similar demographic characteristics
Related Therapeutic Areas
Sponsors
Leads: Ankara University
Collaborators: Atılım University, Hacettepe University

This content was sourced from clinicaltrials.gov